Confirmation of Family Cancer History Reported in a Population-Based Survey

被引:80
作者
Mai, Phuong L. [1 ]
Garceau, Anne O. [2 ]
Graubard, Barry I. [1 ]
Dunn, Marsha [3 ]
McNeel, Timothy S. [4 ]
Gonsalves, Lou [5 ]
Gail, Mitchell H. [1 ]
Greene, Mark H. [1 ]
Willis, Gordon B. [2 ]
Wideroff, Louise [6 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20852 USA
[2] NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20852 USA
[3] Westat Corp, Rockville, MD USA
[4] Informat Management Serv Inc, Silver Spring, MD USA
[5] Connecticut Tumor Registry, Hartford, CT USA
[6] Natl Inst Drug Abuse, Div Epidemiol Serv & Prevent Res, NIH, Bethesda, MD USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2011年 / 103卷 / 10期
基金
美国国家卫生研究院;
关键词
DEATH CERTIFICATE; BREAST-CANCER; ACCURACY; RISK; COMMUNICATION; HEALTH; TOOL; INFORMATION; SENSITIVITY; SOCIETY;
D O I
10.1093/jnci/djr114
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Knowledge of family cancer history is essential for estimating an individual's cancer risk and making clinical recommendations regarding screening and referral to a specialty cancer genetics clinic. However, it is not clear if reported family cancer history is sufficiently accurate for this purpose. Methods In the population-based 2001 Connecticut Family Health Study, 1019 participants reported on 20 578 first-degree relatives (FDR) and second-degree relatives (SDR). Of those, 2605 relatives were sampled for confirmation of cancer reports on breast, colorectal, prostate, and lung cancer. Confirmation sources included state cancer registries, Medicare databases, the National Death Index, death certificates, and health-care facility records. Sensitivity, specificity, positive predictive value, and negative predictive value were calculated for reports on lung, colorectal, breast, and prostate cancer and after stratification by sex, age, education, and degree of relatedness and used to estimate report accuracy. Pairwise t tests were used to evaluate differences between the two strata in each stratified analysis. All statistical tests were two-sided. Results Overall, sensitivity and positive predictive value were low to moderate and varied by cancer type: 60.2% and 40.0%, respectively, for lung cancer reports, 27.3% and 53.5% for colorectal cancer reports, 61.1% and 61.3% for breast cancer reports, and 32.0% and 53.4% for prostate cancer reports. Specificity and negative predictive value were more than 95% for all four cancer types. Cancer history reports on FDR were more accurate than reports on SDR, with reports on FDR having statistically significantly higher sensitivity for prostate cancer than reports on SDR (58.9% vs 21.5%, P =.002) and higher positive predictive value for lung (78.1% vs 31.7%, P <.001), colorectal (85.8% vs 43.5%, P =.004), and breast cancer (79.9% vs 53.6%, P =.02). Conclusions General population reports on family history for the four major adult cancers were not highly accurate. Efforts to improve accuracy are needed in primary care and other health-care settings in which family history is collected to ensure appropriate risk assessment and clinical care recommendations.
引用
收藏
页码:788 / 797
页数:10
相关论文
共 38 条
[1]   Family history-taking in community family practice: Implications for genetic screening [J].
Acheson, LS ;
Wiesner, GL ;
Zyzanski, SJ ;
Goodwin, MA ;
Stange, KC .
GENETICS IN MEDICINE, 2000, 2 (03) :180-185
[2]  
[Anonymous], 1996, Guide to Clinical Preventive Services
[3]  
[Anonymous], AHRQ PUBLICATION
[4]   The sensitivity of medicare data for identifying incident cases of invasive melanoma (United States) [J].
Barzilai, DA ;
Koroukian, SM ;
Neuhauser, D ;
Cooper, KD ;
Rimm, AA ;
Cooper, GS .
CANCER CAUSES & CONTROL, 2004, 15 (02) :179-184
[5]  
Berg AO, 2009, ANN INTERN MED, V151, P872, DOI [10.7326/0000605-200912150-00165, 10.7326/0003-4819-151-12-200912150-00165]
[6]   The sensitivity of medicare claims data for case ascertainment of six common cancers [J].
Cooper, GS ;
Yuan, Z ;
Stange, KC ;
Dennis, LK ;
Amini, SB ;
Rimm, AA .
MEDICAL CARE, 1999, 37 (05) :436-444
[7]   Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: An example from the Mayo Lung Project [J].
Doria-Rose, V. Paul ;
Marcus, Pamela M. .
LUNG CANCER, 2009, 63 (02) :295-300
[8]  
Douglas FS, 1999, J MED GENET, V36, P309
[9]   Colorectal cancer deaths as determined by expert committee and from death certificate: A comparison. The Minnesota Study [J].
Ederer, F ;
Geisser, MS ;
Mongin, SJ ;
Church, TR ;
Mandel, JS .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1999, 52 (05) :447-452
[10]   Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention [J].
Freedman, AN ;
Graubard, BI ;
Rao, SR ;
McCaskill-Stevens, W ;
Ballard-Barbash, R ;
Gail, MH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (07) :526-532